Working…
ClinicalTrials.gov
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Key Record Dates

ClinicalTrials.gov Identifier: NCT00268359
Brief Title: Bevacizumab and Irinotecan in Treating Patients With Recurrent or Refractory Gliomas

First Submitted : December 20, 2005
First Submitted that Met QC Criteria : December 20, 2005
First Posted : December 22, 2005 (Estimate)

Last Update Submitted that Met QC Criteria : July 18, 2014
Last Update Posted : July 21, 2014 (Estimate)